PRA-216

DRUG2 trials

Sponsors

Prana Therapies Inc

Conditions

Chronic Obstructive Pulmonary Disease (COPD)Mild to Moderate Asthma

Phase 1

Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma

RecruitingNCT07245368

Prana Therapies IncMild to Moderate Asthma

Start: 2025-11-04End: 2027-01-31Target: 96Updated: 2026-08-06

Phase 2

PRA-216 COPD Safety and Biomarker Study

Not yet recruitingNCT07730281

Prana Therapies IncChronic Obstructive Pulmonary Disease (COPD)

Start: 2026-08-01End: 2027-09-01Target: 40Updated: 2026-07-28